SnoreLab

SnoreLab is the No.1 iOS and Android app for recording, tracking and reducing snoring

General Information
Company Name
SnoreLab
Founded Year
2012
Location (Offices)
London, United Kingdom +1
Founders / Decision Makers
Number of Employees
2
Industries
-
Funding Stage
-
Social Media

SnoreLab - Company Profile

SnoreLab, founded in 2012, offers the No.1 iOS and Android app for recording, tracking, and reducing snoring. The app has recorded over 50 million nights of sleep, helping millions of users better understand and eliminate their snoring problem. With a user-friendly interface, users can simply set SnoreLab next to their bed at night and receive a Snore Score in the morning, detailing the frequency and intensity of their snoring, along with audio recordings. The app aims to assist individuals in identifying effective ways to reduce snoring. Despite the absence of specific information on industries and headquarters, SnoreLab's extensive user base and substantial sleep data present significant potential for growth and further development.

Taxonomy: sleep monitoring, snoring reduction, health tech, sleep quality, digital health, health awareness, wellness tracking

Funding Rounds & Investors of SnoreLab (0)

View All

There is no investment information

Latest News of SnoreLab

View All

No recent news or press coverage available for SnoreLab.

Similar Companies to SnoreLab

View All
Alpha Sleep Labs - Similar company to SnoreLab
Alpha Sleep Labs Empowering restful nights and revitalized days through expert sleep disorder diagnosis and treatment.
Zelegent - Similar company to SnoreLab
Zelegent Sleep Better. Live Better. Reduce the severity of snoring and the associated negative health effects.
Nasal Aid - Similar company to SnoreLab
Nasal Aid NasalAid develops airway monitoring systems and treatments.
The Snore Shop - Similar company to SnoreLab
The Snore Shop Get more out of your waking hours
AppySleep (OTCQB: APYP) - Similar company to SnoreLab
AppySleep (OTCQB: APYP) Say Good-Night to Snoring. Once and For All.